Laripront tablets. Instruction on indications and contraindications for use

Tablets "Laripront" - one of the preparations of a wide spectrum of action, which is used for various inflammations of the oral cavity of various etiologies. The components of Laripront, dequalinium chloride and lysozyme hydrochloride, inhibit the growth of Candida microbes, viruses and fungi, which are often the cause of various inflammatory processes in the mouth, throat and larynx, as the ability of the body to resist the disease decreases.

In particular, in the annotations to the various batches of the release of the Laripront tablets, the instruction explains that the enzyme lysozyme hydrochloride, interacting with the viruses, reduces their ability to penetrate into it, thus having an antiviral effect.

The antimicrobial effect of the drug is due, on the one hand, to the ability of dequalinium chloride to reduce the surface tension, and on the other hand, by the action of lysozyme, which, through the first component, penetrates through the cell membranes and inhibits the development of Gram-positive and Gram-negative microorganisms, as well as fungal formations, Antiseptics.

In addition to anti-inflammatory, lysozyme also has mucolytic and hemostatic action, blocking histamine, deactivating heparin and splitting mucopolysaccharides.

All these properties determine the breadth of the application area of the drug "Laripront", the instruction to which prescribes to use it to treat a whole range of diseases of the oral cavity, pharynx and larynx. Namely:

• angina;
• tonsillitis;
• laryngitis;
• pharyngitis;
• Inflammation of periodontal disease;
• stomatitis;
• Preparation for surgical operations in the oral cavity and postoperative period.

Laripront tablets - instructions for use

Take the drug "Laripront" is necessary for 1 tablet every two hours, holding it in the mouth or under the root of the tongue, until it dissolves completely.

As for contraindications to taking the "Laripront", the instruction informs about the possibility of allergic reactions to individual components of the drug. Often these reactions are quite long and have unpleasant consequences for the body. Therefore, Laripront tablets for children and pregnant women should be used with caution.

Moreover, children are not always able to keep in their mouth an unpleasant pinch of the mucous membrane, and most often either swallow it, or simply spit out, thereby nullifying the effect of the drug. However, for infants, you can dissolve one fourth of the tablet in a small amount of water, dip this mixture with a pacifier and give the baby. In any case, before starting treatment of children with the drug "Laripront", you need to consult a pediatrician.

As an alternative, to reduce the infection of the oral cavity, you can use other drugs with a similar effect. For example, the agent "Geksoral" in the form of an aerosol.

Concerning compatibility with other means, it can be said that the drug "Laripront" instruction is not advised to apply simultaneously with them.

The drug "Laripront" can be used as a preventive agent - the effectiveness of this drug will be higher than during admission already with the disease. It is also better to take the medicine "Laripront" with the appearance of the first symptoms of ARVI.

The duration of the course of treatment with the drug "Laripront" is not specified specifically by the instruction. Like the dosage, the duration of the treatment period depends on the disease itself, and also on the degree of its severity. The effect of the drug is of an individual nature - someone helps at once, but someone does not. In some cases, the use of "Laripront" does not bring any result at all.